GRPEL1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.691800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.528240E-01
Normal-vs-Stage2
2.713800E-01
Normal-vs-Stage3
9.825600E-01
Normal-vs-Stage4
2.073200E-01
Stage1-vs-Stage2
6.641400E-01
Stage1-vs-Stage3
1.414400E-01
Stage1-vs-Stage4
6.158200E-01
Stage2-vs-Stage3
2.138400E-01
Stage2-vs-Stage4
9.021600E-01
Stage3-vs-Stage4
2.541400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.677400E-01
Normal-vs-AfricanAmerican
2.081400E-01
Normal-vs-Asian
3.653400E-01
Caucasian-vs-AfricanAmerican
6.146600E-01
Caucasian-vs-Asian
5.657600E-01
AfricanAmerican-vs-Asian
9.009600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.362600E-01
Normal-vs-Female
2.065200E-01
Male-vs-Female
2.098000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.647600E-01
Normal-vs-Age(41-60Yrs)
1.650560E-01
Normal-vs-Age(61-80Yrs)
3.558200E-01
Normal-vs-Age(81-100Yrs)
2.073800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.143000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.707200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.091000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.537600E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.909600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.113400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.384400E-01
Normal-vs-Daily Drinker
2.299200E-01
Normal-vs-Weekly Drinker
4.905600E-01
Normal-vs-Occasional Drinker
1.386160E-01
Normal-vs-Social Drinker
2.829000E-01
Non Drinker-vs-Daily Drinker
2.315000E-01
Non Drinker-vs-Weekly Drinker
9.835600E-01
Non Drinker-vs-Occasional Drinker
2.082800E-01
Non Drinker-vs-Social Drinker
8.763000E-01
Daily Drinker-vs-Weekly Drinker
3.609800E-01
Daily Drinker-vs-Occasional Drinker
9.837800E-01
Daily Drinker-vs-Social Drinker
3.503000E-01
Weekly Drinker-vs-Occasional Drinker
3.160000E-01
Weekly Drinker-vs-Social Drinker
9.119400E-01
Occasional Drinker-vs-Social Drinker
2.788600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.668600E-01
Normal-vs-Grade 2
9.425600E-01
Normal-vs-Grade 3
8.978600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.624560E-01
Grade 1-vs-Grade 3
7.791800E-02
Grade 1-vs-Grade 4
9.668600E-01
Grade 2-vs-Grade 3
4.344400E-01
Grade 2-vs-Grade 4
9.425600E-01
Grade 3-vs-Grade 4
8.978600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.813200E-01
Normal-vs-NonDiabetic
2.534600E-01
Diabetic-vs-NonDiabetic
9.281000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.325570E-01
Normal-vs-NoPancreatitis
3.247000E-01
Pancreatitis-vs-NoPancreatitis
3.129600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.364400E-01
Normal-vs-N1
2.687800E-01
N0-vs-N1
7.943400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.905800E-02
Normal-vs-TP53-NonMutant
4.522800E-01
TP53-Mutant-vs-TP53-NonMutant
1.017480E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
